Article Information
History
- October 18, 2024.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Chisato IzumI, MD, PhD1,†,
- Masashi Amano, MD, PhD1,
- Satsuki Fukushima, MD, PhD2,
- Hitoshi Yaku, MD, PhD3,
- Kiyoyuki Eishi, MD, PhD4,
- Taichi Sakaguchi, MD, PhD5,
- Nobuhisa Ohno, MD, PhD6,
- Arudo Hiraoka, MD, PhD7,
- Kenji Okada, MD, PhD8,
- Yoshikatsu Saiki, MD, PhD9,
- Takashi Miura, MD, PhD10,
- Tatsuhiko Komiya, MD, PhD11,
- Manabu Minami, MD, PhD12,
- Haruko Yamamoto, MD, PhD12,
- Katsuhiro Omae, PhD12,
- ENBALV Trial investigators*
- 1Department of Heart Failure and Transplant, National Cerebral and Cardiovascular Center, Suita, Japan
- 2Department of Cardiovascular Surgery, National Cerebral and Cardiovascular Center, Suita, Japan
- 3Department of Cardiovascular Surgery, Kyoto Prefectural University of Medicine. Kyoto, Japan
- 4Department of Cardiovascular Surgery, Hakujyuji Hospital. Fukuoka, Japan
- 5Department of Cardiovascular Surgery, Hyogo Medical University, Nishinomiya, Japan
- 6Department of Cardiovascular Surgery, Kokura Memorial Hospital
- 7Department of Cardiovascular Surgery, Sakakibara Heart Institute of Okayama
- 8Department of Cardiovascular Surgery, Kobe University Graduate School of Medicine
- 9Department of Cardiovascular Surgery, Tohoku University Graduate School of Medicine
- 10Department of Cardiovascular Surgery, Nagasaki University Graduate School of Biomedical Sciences
- 11Department of Cardiac Surgery, Kurashiki Central Hospital
- 12Department of Data Science, National Cerebral and Cardiovascular Center, Suita, Japan
- ↵†Address for correspondence: Chisato Izumi, MD, PhD, Director, Department of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, 6-1 Kishibe Shimmachi, Suita, Osaka 564-8565 Japan. Tel: +81-661701070, Fax: +81-661701069, E-mail: izumi-ch{at}ncvc.go.jp
Posted October 18, 2024.
Efficacy and Safety of Edoxaban in Anticoagulant Therapy Early after Surgical Bioprosthetic Valve Replacement: the ENBALV trial
